Brief: BioInvent Q1 Sales SEK 13.4 Million

BioInvent International AB

29/04/2026 07:00

Apr 29 (Reuters) - BioInvent Q1 adjusted EPS SEK -1.81.

Q1 adjusted free cash flow SEK -132.8 million

Q1 net income SEK -119.2 million